-
Ventyx Biosciences: From Small-Cap Biotech to Big Pharma Contender?
24 Oct 2025 07:48 GMT
Ventyx Biosciences (NASDAQ:VTYX) experienced a dramatic surge on October 23, 2025, with shares rocketing over 105% following the announcement of positive Phase 2 clinical trial results for VTX3232, an experimental oral therapy targeting cardiovascular …
-
Medicus Pharma begins phase 2 clinical trial in UAE for SkinJect...
24 Oct 2025 03:51 GMT
… #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer # … Investing #MedicalResearch #SkinCancer #BasalCellCarcinoma #BiotechNews #CancerResearch #UAEHealth #NonInvasiveTherapy #Doxorubicin #ClinicalTrials …
-
Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm
24 Oct 2025 03:12 GMT
… on negotiations with a big pharma company that has the inside … of the San Diego-based biotech’s drug on inflammation. This … could be the next big pharma company to strike a deal … Ventyx that also gave the pharma giant the right of first …
-
<![CDATA[Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments ]]>
24 Oct 2025 02:28 GMT
The pharma sector continues to draw investments … of multiple offers from leading biotech institutions, as well as from … this molecule forward with Teijin Pharma,” said Emma Tinsley, CEO of …
-
Time has never been better for Pharma breakthroughs than today: Bayer executive Stefan Oelrich
23 Oct 2025 21:43 GMT
… in the news on the pharma front. Where is Bayer placed … US. As we acquired these biotech companies, one of the organisational … if they were continuing as biotech firms. We created what we … ; we operate them as independent biotech units that buy services from …
-
Biotech recovery in Q3 2025 as venture funding grows 70.9% from Q2 2025
23 Oct 2025 19:01 GMT
… In Pharma – Q3 2025 report revealed that the biotech industry … venture capital investments in biotech.
According to GlobalData’s … that continue to drive biotech deal-making activity, representing … drug conjugates (ADCs).
The biotech industry saw a resurgence …
-
Small Cell Lung Cancer Market Research 2025-2035, Competitive Analysis of Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Merck, Pfizer, PharmaMar, Sun Pharma, Teva - ResearchAndMarkets.com
23 Oct 2025 15:37 GMT
DUBLIN--(BUSINESS WIRE)--Oct 23, 2025--
The "Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets. …
-
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
23 Oct 2025 12:45 GMT
Significant milestones are approaching in drug development; additional digital asset purchases expected Preparation for FDA IND application expected to commence before year-end SARASOTA, FL, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO …
-
Biotechs brush off sector headwinds in venture financing rebound
23 Oct 2025 11:24 GMT
… lacklustre few years for the biotech investment scene, deals substantially recovered … macroeconomic instability to the global pharma industry amongst others. This includes … Alison Labya, senior business fundamentals pharma analyst at GlobalData.
Financing in …
-
17 stocks including Infosys, Torrent Pharma, DroneAcharya, Jain Resource, HCL Tech, Airtel, Rubicon Research, BEL, Nectar Life, NMDC, Zaggle will remain in focus on Thursday
23 Oct 2025 05:57 GMT
… of India has approved Torrent Pharma‘s proposed ₹19,500-crore … for the Infosys buyback.
Coastal Biotech Pvt Ltd, subsidiary of Coastal …
About
© 1995-2025